sumamed 500 mg apvalkotās tabletes
teva pharma b.v., netherlands - azitromicīns - apvalkotā tablete - 500 mg
sumamed forte 200 mg/5 ml pulveris iekšķīgi lietojamas suspensijas pagatavošanai
teva pharma b.v., netherlands - azitromicīns - pulveris iekšķīgi lietojamas suspensijas pagatavošanai - 200 mg/5 ml
zylumit 500 mg apvalkotās tabletes
rivopharm ltd., ireland - azitromicīns - apvalkotā tablete - 500 mg
azibiot 500 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - azitromicīns - apvalkotā tablete - 500 mg
azithromycin krka 500 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - azitromicīns - apvalkotās tabletes - 500 mg
azithromycin teva 500 mg disperģējamās tabletes
teva pharma b.v., netherlands - azitromicīns - disperģējamā tablete - 500 mg
sarclisa
sanofi winthrop industrie - isatuximab - multiple mieloma - antineoplastiski līdzekļi - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
mirzaten 30 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - mirtazapīns - apvalkotā tablete - 30 mg